Insider Transactions in Q4 2024 at Singular Genomics Systems, Inc. (OMIC)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
306
+0.22%
|
-
|
|
Dec 16
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
306
-48.49%
|
-
|
|
Dec 16
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
180
-22.19%
|
$3,600
$20.16 P/Share
|
|
Dec 15
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
486
+37.47%
|
-
|
|
Dec 15
2024
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+0.16%
|
-
|
|
Dec 15
2024
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
209
+2.27%
|
-
|
|
Nov 12
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
1,212
+0.85%
|
-
|
|
Nov 12
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,212
-78.85%
|
-
|
|
Nov 12
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
695
-31.14%
|
$15,290
$22.55 P/Share
|
|
Nov 12
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,907
+46.07%
|
-
|
|
Nov 09
2024
|
Jyotsna Ghai Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+9.04%
|
-
|
|
Nov 09
2024
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+0.32%
|
-
|
|
Nov 09
2024
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+5.44%
|
-
|
|
Oct 02
2024
|
Jyotsna Ghai Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,666
+42.37%
|
-
|